Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000902664-25-005133·Anika Therapeutics, Inc.
Schedule 13D ownership disclosure
ANIKA THERAPEUTICS INC
Common Stock, par value $0.01 per share · CUSIP: 035255108
Event date: 2025-11-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Caligan Partners LPReported CIK 0001727492
Shares: 1,435,130.00 · Class: 9.95%
- David JohnsonReported CIK 0001785557
Shares: 1,435,130.00 · Class: 9.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005133
- Form type
- SCHEDULE 13D/A
- Filer
- Anika Therapeutics, Inc.
- CIK
- CIK 898437
- Filed
- Nov 21, 2025
- Reporting period
- Nov 19, 2025
- Description
- Schedule 13D beneficial ownership